Diagnostic criteria for mild cognitive impairment in Parkinson's disease: <i>Movement</i> Disorder Society Task Force guidelines

Movement Disorders - Tập 27 Số 3 - Trang 349-356 - 2012
Irene Litvan1,2, Jennifer G. Goldman3, Alexander I. Tröster4, Ben Schmand5,6, Daniel Weintraub7,8, Ronald C. Petersen9, Brit Mollenhauer10,11, Charles H. Adler12, Karen Marder13, Caroline H. Williams‐Gray14, Dag Aarsland15,16, Jaime Kulisevsky17,18, Manuel Rodrı́guez17,19,20,21, David J. Burn22, Roger A. Barker14, Murat Emre23
1Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, Kentucky, USA
2Movement Disorders Program, Frazier Rehab Neuroscience Institute, Louisville, Kentucky, USA
3Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois, USA
4Department of Neurology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA
5Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands
6Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands
7Departments of Psychiatry and Neurology, University of Pennsylvania School of Medicine Philadelphia, Pennsylvania, USA
8Parkinson's Disease and Mental Illness Research, Education and Clinical Centers, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA
9Mayo Alzheimer's Disease Research Center, Mayo Clinic, Rochester, Minnesota, USA
10Georg-August University Goettingen, Goettingen, Germany
11Paracelsus-Elena-Klinik, Kassel, Germany
12Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA
13Taub Institute on Alzheimers Disease and the Aging Brain, Department of Neurology, New York Presbyterian Hospital, Columbia University Medical Center, NY, New York, USA
14Cambridge Center for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
15Akershus University Hospital, University of Oslo, Oslo, Norway
16Karolinska Institute, Stockholm, Center for Age-Related Medicine, Stavanger University Hospital, Stockholm, Sweden
17Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Barcelona, Spain
18Movement Disorders Unit, Neurology Department, Sant Pau Hospital and Institute of Biomedical Research (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, Spain
19Department of Neurology, Hospital Donostia, Donostia, Spain
20IKERBASQUE, Basque Foundation for Science Bilbao, Bilbao, Spain
21Neuroscience Unit, BioDonostia Research Institute, San Sebatian, San Sebatian, Spain
22Institute for Aging and Health, Newcastle University, Newcastle upon Tyne, UK
23Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

Tóm tắt

Abstract

Mild cognitive impairment is common in nondemented Parkinson's disease (PD) patients and may be a harbinger of dementia. In view of its importance, the Movement Disorder Society commissioned a task force to delineate diagnostic criteria for mild cognitive impairment in PD. The proposed diagnostic criteria are based on a literature review and expert consensus. This article provides guidelines to characterize the clinical syndrome and methods for its diagnosis. The criteria will require validation, and possibly refinement, as additional research improves our understanding of the epidemiology, presentation, neurobiology, assessment, and long‐term course of this clinical syndrome. These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage. © 2012 Movement Disorder Society

Từ khóa


Tài liệu tham khảo

10.1002/mds.23823

10.1002/mds.21956

10.1001/archneur.1996.00550060082020

10.1001/archneur.60.3.387

10.1212/WNL.0b013e3181f39d0e

10.1016/j.jalz.2011.03.008

10.1111/j.1365-2796.2004.01388.x

10.1001/archneurol.2009.266

JesteD BlackerD BlazerD et al. Neurocognitive disorders: a proposal from the DSM‐5 Neurocognitive Disorders Work Group 2010. Available at:www.dsm5.org/Proposed%20Revision%20Attachments/APA%20Neurocognitive%20Disorders%20Proposal%20for%20DSM‐5.pdf.

10.1097/JGP.0b013e3182051ab4

10.1002/mds.20974

10.1177/0891988705277540

10.1136/jnnp.64.2.178

10.1002/mds.10280

10.1212/WNL.45.9.1691

10.1002/mds.20216

10.1093/brain/awp245

10.1002/mds.21507

10.1002/mds.21844

10.1136/jnnp.51.6.745

10.1212/WNL.0b013e3181c34b47

10.1212/WNL.0b013e3181fc29c9

10.1159/000326212

10.1002/mds.22007

10.1212/WNL.0b013e318230208a

10.1037/0022-006X.59.1.12

10.1097/JGP.0b013e3181e56d5a

10.1002/mds.23592

10.1002/gps.1049

10.1001/archneur.1989.00520450025014

10.1002/mds.23331

10.1002/mds.21453

10.1002/mds.23391

10.1017/S1355617710000330

10.1001/archneur.61.12.1906

10.1212/01.wnl.0000278114.14096.74

10.1097/JGP.0b013e3181b215ec

10.1007/s00702-006-0615-2

10.1212/WNL.59.3.408

Lezak MD, 2004, Neuropsychological Assessment

Gazzaniga MS, 2009, Cognitive Neuroscience: The Biology of the Mind, 10.7551/mitpress/8029.001.0001

10.1002/mds.21677

10.1017/S1355617707071160

10.1007/s11065-008-9055-0

10.1007/s00702-010-0370-2

10.1093/brain/awh067

10.1016/j.acn.2007.05.004

Arbuthnott K, 2000, Trail making test, part B as a measure of executive control: validation using a set‐switching paradigm, J Clinical Exp Neuropsychology, 22, 518, 10.1076/1380-3395(200008)22:4;1-0;FT518

10.1002/mds.22510

10.1159/000094871

10.1212/WNL.0b013e3181f39a78

10.1007/s00415-005-0756-5

10.1111/j.1468-1331.2009.02706.x

10.3174/ajnr.A1556

10.1136/jnnp.2009.199950

10.1001/archneurol.2011.17

National Institute of Neurological Disorders and Stroke. NINDS common data elements.2011. Available at:www.ninds.nih.gov/research/clinical_research/toolkit/common_data_elements.htm.

10.1002/mds.22017

10.1002/mds.22506

10.1136/jnnp.2006.112367

10.1002/mds.22173